Assessment of methylphenidate-induced changes in binding of continuously infused [11C]-raclopride in healthy human subjects: correlation with subjective effects
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Rationale The dopaminergic system has been implicated in the pathogenesis and treatment of a variety of neuropsychiatric disorders. It has been shown that information on endogenous dopamine (DA) release can be obtained noninvasively by combining positron emission tomography with a dopaminergic challenge. This approach is based on the assumption that an injected radiolabeled ligand competes with the neurotransmitter for the same receptor. Increases in DA release will therefore result in a decreased binding of the radioligand.Objectives We investigated the effect of the DA reuptake blocker methylphenidate (MP) on the binding of the D(2) receptor ligand [(11)C]-raclopride (RAC).Methods The effect of a 0.25 mg/kg intravenous dose of MP was studied in six healthy volunteers. RAC was administered as a bolus followed by constant infusion, and subjective effects were assessed using verbal rating scales.Results Control scans without MP administration showed that the mean RAC binding reached stable values approximately 30 min after start of the infusion. MP administration induced a 24% decrease in RAC binding in the total striatum. Correlations were found between the MP-induced change in euphoria and the percent change in binding potential (DeltaBP) in the dorsal striatum and between baseline anxiety and DeltaBP in the dorsal and middle striatum. We also found a negative correlation between baseline BP in the dorsal striatum and change in euphoria.Conclusions Our results comply with previous findings, indicating the feasibility of the bolus infusion design combined with a relatively low MP dose to study dopaminergic (dys)function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“DA release, especially in the striatum, has been implicated in the process of rewarding or reinforcing effects of certain stimuli (Ikemoto and Panksepp 1999; McClure et al. 2004; Spanagel and Weiss 1999; Ungless 2004; Wise 2004).”
BackgroundSeparate neural systems value immediate and delayed monetary rewards
McClure, S. M., Laibson, D. I., Loewenstein, G., & Cohen, J. D. (2004) · Science · doi:10.1126/science.1100907 · Cited by 3,089
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813 · cited 1×
“The involvement of dopamine (DA) in these disorders may be related to its function in reward processing (Kapur 2003; Kunig et al. 2000; Schmidt et al. 2001).”
BackgroundIkemoto, S., & Panksepp, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00023-5 · Cited by 1,450
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease
de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991
Cited by
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…in ligand binding potential in PET studies (Booij et al., 1997; Clatworthy et al., 2009; Montgomery et al., 2007; Spencer et al., 2006, 2010; Udo de Haes et al., 2005; Volkow et al., 1994, 2001, 2004; Wang et al., 1999), with evidence to indicate that this effect is related to binding to the DAT…”
InfluentialIncreased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving
Wong, D. F., Kuwabara, H., Schretlen, D. J., Bonson, K. R., Zhou, Y., Nandi, A., Brašić, J. R., Kimes, A. S., Maris, M. A., Kumar, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301194 · Cited by 311
Clatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-08.2009 · Cited by 229
“…which reported that D-amphetamine in humans (Drevets et al., 2001; Martinez et al., 2003) and in the baboon (Drevets et al., 1999), as well as intravenous methylphenidate in humans (Udo de Haes et al., 2005), produced the greatest overall changes in BP in ventral striatum and putamen.”
BackgroundInvestigating the Dopaminergic Synapse In Vivo. I. Molecular Imaging Studies in Humans
Nikolaus, S., Antke, C., Kley, K., Poeppel, T. D., Hautzel, H., Schmidt, D., & Müller, H. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.6.439 · Cited by 51
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD
Fan, X., & Hess, E. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.011 · Cited by 55
“…comparable increases in extracellular dopamine in humans as assessed by positron emission tomography (PET) imaging of psychostimulant-induced displacement of [11C]raclopride binding (Breier et al., 1997; Volkow et al., 2001; Cardenas et al., 2004; Oswald et al., 2005; Udo de Haes et al., 2005).”
Background
Metadata
- Authors
- Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A.
- Affiliations
- University Medical Center Groningen (NL)
- Venue
- Psychopharmacology
- Published
- 2005-10-12
- Volume
- 183
- Issue
- 3
- Pages
- 322-330
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2103399368
- Cited by
- 18
- References
- 63
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2014: 2 · 2012: 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methylphenidate, [11C]raclopride, dopamine release, striatum, euphoria, anxiety, subjective effects, binding potential, bolus infusion
- MeSH terms
- Adolescent, Adult, Blood Pressure, Carbon Radioisotopes, Female, Heart Rate, Humans, Male, Methylphenidate, Receptors, Dopamine D2, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of methylphenidate-induced changes in binding of continuously infused [11C]-raclopride in healthy human subjects: correlation with subjective effects. https://app.cochat.ai/papers/10.1007/s00213-005-0193-2
- The paper
- Udo de Haes, J. I., Kortekaas, R., Van Waarde, A., Maguire, R. P., Pruim, J., & den Boer, J. A. (2005). Assessment of methylphenidate-induced changes in binding of continuously infused [11C]-raclopride in healthy human subjects: correlation with subjective effects. Psychopharmacology. https://doi.org/10.1007/s00213-005-0193-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.